首页> 外文期刊>Circulation journal >Age-Related Differences in the Effects of Initial Aortic Valve Replacement vs. Conservative Strategy on Long-Term Outcomes in Asymptomatic Patients With Severe Aortic Stenosis
【24h】

Age-Related Differences in the Effects of Initial Aortic Valve Replacement vs. Conservative Strategy on Long-Term Outcomes in Asymptomatic Patients With Severe Aortic Stenosis

机译:初始主动脉瓣置换术效应对严重主动脉狭窄的无症状患者长期成果影响的年龄相关差异

获取原文
       

摘要

Background: This study aimed to evaluate the effect of the initial aortic valve replacement (AVR) strategy relative to a conservative strategy on long-term outcomes stratified by age among asymptomatic patients with severe aortic stenosis (AS). Methods?and?Results: Among 1,808 asymptomatic severe AS patients in the CURRENT AS registry, there were 1,166 patients aged ≥75 years (initial AVR: n=124, and conservative: n=1,042), and 642 patients with age 75 years (initial AVR: n=167, and conservative: n=475). Median follow-up interval was 1,280 (interquartile range [IQR]: 1,012–1,611) days, and 1461 (IQR: 1,132–1,886) days in patients aged ≥ and 75 years, respectively. The favorable effect of the initial AVR strategy relative to conservative strategy for heart failure (HF) hospitalization was seen regardless of the age stratum (≥75 years: adjusted hazard ratio [HR] 0.13, 95% confidence interval [CI] 0.05–0.34, and 75 years: HR 0.37, 95% CI 0.14–0.99, interaction P=0.35). However, the lower mortality risk of the initial AVR strategy relative to conservative strategy was significant in patients aged ≥75 years, but not in patients 75 years, with significant interaction (HR 0.35, 95% CI 0.20–0.61, and HR 0.69, 95% CI 0.41–1.16, interaction P=0.016). Conclusions: The benefit of initial AVR in reducing HF hospitalization in asymptomatic patients with severe AS was consistently seen regardless of age. The magnitude of mortality benefit of initial AVR was greater in super-elder patients than in non-super-elder patients.
机译:背景:本研究旨在评估初始主动脉瓣更换(AVR)策略相对于长期成果的保守策略的影响,无症状患者严重主动脉狭窄(AS)。方法:结果:在当前患者作为登记处的患者1,808无症状严重中,有1,166名患者≥75岁(初始AVR:n = 124,保守:n = 1,042),和642名患者年龄<75岁(初始AVR:n = 167,保守:n = 475)。中位后续间隔为1,280(别名(IQR]:1,012-1,611)天,1461(IQR:1,132-1,886)分别为≥<75岁。无论年龄层(≥75年:调整后的危险比[HR] 0.13,95%置信区间[CI] 0.05-0.34,,初始AVR策略相对于心力衰竭的保守策略(HF)住院策略的良好影响<75年:HR 0.37,95%CI 0.14-0.99,相互作用P = 0.35)。然而,初始AVR策略相对于保守策略的较低死亡率风险对于≥75岁的患者而言,但在患者<75岁,具有显着的相互作用(HR 0.35,95%CI 0.20-0.61和HR 0.69, 95%CI 0.41-1.16,相互作用P = 0.016)。结论:初始AVR在减少严重的无症状患者的HF住院中的益处,无论年龄段,始终如一地看作。超老年患者的初始AVR的死亡效益大于非超老年患者。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号